These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 9085849)

  • 1. Probing accessible sites for ribozymes on human acetylcholinesterase RNA.
    Birikh KR; Berlin YA; Soreq H; Eckstein F
    RNA; 1997 Apr; 3(4):429-37. PubMed ID: 9085849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic selectivity of complementary nucleic acids: bcr-abl-directed antisense RNA and ribozymes.
    Kronenwett R; Haas R; Sczakiel G
    J Mol Biol; 1996 Jun; 259(4):632-44. PubMed ID: 8683570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Engineered RNase P ribozymes inhibit gene expression and growth of cytomegalovirus by increasing rate of cleavage and substrate binding.
    Trang P; Hsu A; Zhou T; Lee J; Kilani AF; Nepomuceno E; Liu F
    J Mol Biol; 2002 Jan; 315(4):573-86. PubMed ID: 11812131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinetic analysis of precursor M1 RNA molecules for exploring substrate specificity of the N-terminal catalytic half of RNase E.
    Kim KS; Sim S; Ko JH; Cho B; Lee Y
    J Biochem; 2004 Nov; 136(5):693-9. PubMed ID: 15632310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of antisense and ribozyme accessible sites on native mRNAs: application to NCOA3 mRNA.
    Scherr M; LeBon J; Castanotto D; Cunliffe HE; Meltzer PS; Ganser A; Riggs AD; Rossi JJ
    Mol Ther; 2001 Nov; 4(5):454-60. PubMed ID: 11708882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquisition of novel catalytic activity by the M1 RNA ribozyme: the cost of molecular adaptation.
    Cole KB; Dorit RL
    J Mol Biol; 1999 Oct; 292(4):931-44. PubMed ID: 10525416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guiding ribozyme cleavage through motif recognition: the mechanism of cleavage site selection by a group ii intron ribozyme.
    Su LJ; Qin PZ; Michels WJ; Pyle AM
    J Mol Biol; 2001 Mar; 306(4):655-68. PubMed ID: 11243778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of activities between hammerhead ribozymes and DNA enzymes targeted to L6 BCR-ABL chimeric (b2a2) mRNA.
    Warashina M; Kuwabara T; Taira K
    Nucleic Acids Symp Ser; 1997; (37):213-4. PubMed ID: 9586075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficient RNA ligation by reverse-joined hairpin ribozymes and engineering of twin ribozymes consisting of conventional and reverse-joined hairpin ribozyme units.
    Ivanov SA; Vauléon S; Müller S
    FEBS J; 2005 Sep; 272(17):4464-74. PubMed ID: 16128815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural features of target RNA molecules greatly modulate the cleavage efficiency of trans-acting delta ribozymes.
    Swiatkowska A; Dutkiewicz M; Ciesiołka J
    Biochemistry; 2007 May; 46(18):5523-33. PubMed ID: 17425288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hammerhead ribozymes designed to cleave all human rod opsin mRNAs which cause autosomal dominant retinitis pigmentosa.
    Sullivan JM; Pietras KM; Shin BJ; Misasi JN
    Mol Vis; 2002 Apr; 8():102-13. PubMed ID: 11961505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ribozyme-targeted destruction of RNA associated with autosomal-dominant retinitis pigmentosa.
    Drenser KA; Timmers AM; Hauswirth WW; Lewin AS
    Invest Ophthalmol Vis Sci; 1998 Apr; 39(5):681-9. PubMed ID: 9538873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heterodimer-based analysis of subunit and domain contributions to double-stranded RNA processing by Escherichia coli RNase III in vitro.
    Meng W; Nicholson AW
    Biochem J; 2008 Feb; 410(1):39-48. PubMed ID: 17953512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helicase-attached novel hybrid ribozymes.
    Kawasaki H; Warashina M; Kuwabara T; Taira K
    Methods Mol Biol; 2004; 252():237-43. PubMed ID: 15017053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural biochemistry of a type 2 RNase H: RNA primer recognition and removal during DNA replication.
    Chapados BR; Chai Q; Hosfield DJ; Qiu J; Shen B; Tainer JA
    J Mol Biol; 2001 Mar; 307(2):541-56. PubMed ID: 11254381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Degradation of double-stranded RNA by human pancreatic ribonuclease: crucial role of noncatalytic basic amino acid residues.
    Sorrentino S; Naddeo M; Russo A; D'Alessio G
    Biochemistry; 2003 Sep; 42(34):10182-90. PubMed ID: 12939146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preparation and characterization of ribozyme for tissue inhibitor of metalloproteinases-1 mRNA ribozymes in vitro].
    Wang ZM; Wu JM; Lin ZH; Jiang H; Song YH; Jin YX
    Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Apr; 35(4):387-90. PubMed ID: 12673396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein cofactor-dependent acquisition of novel catalytic activity by the RNase P ribonucleoprotein of E. coli.
    Cole KB; Dorit RL
    J Mol Biol; 2001 Apr; 307(5):1181-212. PubMed ID: 11292334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemically modified oligonucleotides with efficient RNase H response.
    Vester B; Boel AM; Lobedanz S; Babu BR; Raunkjaer M; Lindegaard D; Raunak ; Hrdlicka PJ; Højland T; Sharma PK; Kumar S; Nielsen P; Wengel J
    Bioorg Med Chem Lett; 2008 Apr; 18(7):2296-300. PubMed ID: 18356048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Similarities and differences in the RNase H activities of human immunodeficiency virus type 1 reverse transcriptase and Moloney murine leukemia virus reverse transcriptase.
    Gao HQ; Sarafianos SG; Arnold E; Hughes SH
    J Mol Biol; 1999 Dec; 294(5):1097-113. PubMed ID: 10600369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.